Brief: Mainz Biomed NV - Enters Asset Purchase Agreement On April 9, 2026 For Next Gen Ip Sale - SEC Filing
April 15 (Reuters) - Mainz Biomed NV 4TO.F: MAINZ BIOMED NV - ENTERS ASSET PURCHASE AGREEMENT ON APRIL 9, 2026 FOR NEXT GEN IP SALE - SEC FILING MAINZ BIOMED NV - TO SELL NEXT GEN IP FOR $1.25 MILLION - SEC FILING MAINZ BIOMED NV - SALE OF THE NEXT GEN IP DOES NOT AFFECT OTHER OPERATIONS Source text: [] Further company coverage: 4TO.F ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Quantum Cyber NV
See all newsBrief: Quantum Cyber To Proceed With Pending Litigation Against Adam Gefvert
Brief: Quantum Cyber NV Files Lawsuit Against White Diamond Research, Adam Gefvert And Stocktwits, Inc. In New York Supreme Court
Quantum Cyber jumps on SpaceX stake purchase plan
Brief: Quantum Cyber Signs Loi To Acquire An Estimated 43,000 Square Foot U.S.-Based Manufacturing Facility To Support Mass-Scale Autonomous Drone Production
Brief: Quantum Cyber NV - To Terminate ATM Sales Agreement With Maxim Effective June 7, 2026 - SEC Filing